Katz Richard A, Greger James G, Skalka Anna Marie
Fox Chase Cancer Center, Institute for Cancer Research, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA.
J Cell Biochem. 2005 Apr 1;94(5):880-9. doi: 10.1002/jcb.20358.
The study of retroviruses over the last century has revealed a wide variety of disease-producing mechanisms, as well as apparently harmless interactions with animal hosts. Despite their potential pathogenic properties, the intrinsic features of retroviruses have been harnessed to create gene transfer vectors that may be useful for the treatment of disease. Retroviruses, as all viruses, have evolved to infect specific cells within the host, and such specificities are relevant to both pathogenesis and retrovirus-based vector design. The majority of cells of an animal host are not progressing rapidly through the cell cycle, and such a cellular environment appears to be suboptimal for replication of all retroviruses. Retrovirus-based vectors can therefore be restricted in many important target cells, such as post-mitotic differentiated cells or stem cells that may divide only infrequently. Despite intense interest, our understanding of how cell cycle status influences retroviral infection is still quite limited. In this review, we focus on the importance of the cell cycle as it relates to the early steps in retroviral replication. Retroviruses have been categorized based on their abilities to complete these early steps in non-cycling cells. However, all retroviruses are subject to a variety of cell cycle restrictions. Here, we discuss such restrictions, and how they may block retroviral replication, be tolerated, or overcome.
上个世纪对逆转录病毒的研究揭示了多种致病机制,以及与动物宿主看似无害的相互作用。尽管逆转录病毒具有潜在的致病特性,但其内在特征已被用于构建可能有助于疾病治疗的基因转移载体。与所有病毒一样,逆转录病毒已经进化到能够感染宿主体内的特定细胞,这种特异性与发病机制和基于逆转录病毒的载体设计都相关。动物宿主的大多数细胞不会快速通过细胞周期,这样的细胞环境似乎对所有逆转录病毒的复制都不是最佳的。因此,基于逆转录病毒的载体在许多重要的靶细胞中可能受到限制,例如有丝分裂后分化的细胞或可能很少分裂的干细胞。尽管人们对此兴趣浓厚,但我们对细胞周期状态如何影响逆转录病毒感染的理解仍然相当有限。在这篇综述中,我们关注细胞周期与逆转录病毒复制早期步骤相关的重要性。逆转录病毒已根据它们在非循环细胞中完成这些早期步骤的能力进行了分类。然而,所有逆转录病毒都受到多种细胞周期限制。在这里,我们讨论这些限制,以及它们如何可能阻断逆转录病毒复制、被耐受或被克服。